Structural insights into the human metapneumovirus glycoprotein ectodomain

Journal of Virology

Volumn 88, Issue 19, 2014, Pages 11611-11616

  Leyrat, Cedric ^a   Paesen, Guido C ^a   Charleston, James ^a   Renner, Max ^a   Grimes, Jonathan M ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b DIAMOND LIGHT SOURCE LTD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; G GLYCOPROTEIN, HUMAN METAPNEUMOVIRUS; VIRUS PROTEIN;

ADAPTIVE IMMUNITY; AMINO TERMINAL SEQUENCE; ARTICLE; BIOINFORMATICS; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; GLYCOSYLATION; HUMAN METAPNEUMOVIRUS; IMMUNOMODULATION; INNATE IMMUNITY; LIGHT SCATTERING; NONHUMAN; PROTEIN STRUCTURE; RADIATION SCATTERING; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRUS PARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; HUMAN; IMMUNOLOGY; METABOLISM; METAPNEUMOVIRUS; PROTEIN TERTIARY STRUCTURE;

GLYCOPROTEINS; GLYCOSYLATION; HUMANS; IMMUNITY, INNATE; METAPNEUMOVIRUS; MODELS, MOLECULAR; PROTEIN STRUCTURE, TERTIARY; VIRAL PROTEINS;

EID: 84906987834     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01726-14     Document Type: Article

References (63)

1. Boivin G, Abed Y, Pelletier G, Ruel L, Moisan D, Cote S, Peret TC, Erdman DD, Anderson LJ. 2002. Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups. J. Infect. Dis. 186:1330-1334. http://dx.doi.org/10.1086/344319.
2. Boivin G, De Serres G, Cote S, Gilca R, Abed Y, Rochette L, Bergeron MG, Dery P. 2003. Human metapneumovirus infections in hospitalized children. Emerg. Infect. Dis. 9:634-640. http://dx.doi.org/10.3201 /eid0906.030017.
3. Osterhaus A, Fouchier R. 2003. Human metapneumovirus in the community. Lancet 361:890-891. http://dx.doi.org/10.1016/S0140-6736(03) 12785-7.
4. van den Hoogen BG, de Jong JC, Groen J, Kuiken T, de Groot R, Fouchier RA, Osterhaus AD. 2001. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat. Med. 7:719-724. http://dx.doi.org/10.1038/89098.
5. Herfst S, Mas V, Ver LS, Wierda RJ, Osterhaus AD, Fouchier RA, Melero JA. 2008. Low-pH-induced membrane fusion mediated by human metapneumovirus F protein is a rare, strain-dependent phenomenon. J. Virol. 82:8891-8895. http://dx.doi.org/10.1128/JVI.00472-08.
6. Schowalter RM, Smith SE, Dutch RE. 2006. Characterization of human metapneumovirus F protein-promoted membrane fusion: critical roles for proteolytic processing and low pH. J. Virol. 80:10931-10941. http://dx .doi.org/10.1128/JVI.01287-06.
7. de Graaf M, Schrauwen EJ, Herfst S, van Amerongen G, Osterhaus AD, Fouchier RA. 2009. Fusion protein is the main determinant of metapneumovirus host tropism. J. Gen. Virol. 90:1408-1416. http://dx.doi.org/10 .1099/vir.0.009688-0.
8. Schlender J, Zimmer G, Herrler G, Conzelmann KK. 2003. Respiratory syncytial virus (RSV) fusion protein subunit F2, not attachment protein G, determines the specificity of RSV infection. J. Virol. 77:4609-4616. http://dx.doi.org/10.1128/JVI.77.8.4609-4616.2003.
9. Tang RS, Mahmood K, Macphail M, Guzzetta JM, Haller AA, Liu H, Kaur J, Lawlor HA, Stillman EA, Schickli JH, Fouchier RA, Osterhaus AD, Spaete RR. 2005. A host-range restricted parainfluenza virus type 3 (PIV3) expressing the human metapneumovirus (hMPV) fusion protein elicits protective immunity in African green monkeys. Vaccine 23:1657-1667. http://dx.doi.org/10.1016/j.vaccine.2004.10.009.
10. Skiadopoulos MH, Biacchesi S, Buchholz UJ, Riggs JM, Surman SR, Amaro-Carambot E, McAuliffe JM, Elkins WR, St Claire M, Collins PL, Murphy BR. 2004. The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness. J. Virol. 78:6927-6937. http://dx .doi.org/10.1128/JVI.78.13.6927-6937.2004.
11. Skiadopoulos MH, Biacchesi S, Buchholz UJ, Amaro-Carambot E, Surman SR, Collins PL, Murphy BR. 2006. Individual contributions of the human metapneumovirus F, G, and SH surface glycoproteins to the induction of neutralizing antibodies and protective immunity. Virology 345:492-501. http://dx.doi.org/10.1016/j.virol.2005.10.016.
12. Tedcastle AB, Fenwick F, Robinson MJ, Toms GL. 2014. Immunogenicity in mice of human metapneumovirus with a truncated SH glycoprotein. J. Med. Virol. 86:547-557. http://dx.doi.org/10.1002/jmv.23731.
13. Ryder AB, Tollefson SJ, Podsiad AB, Johnson JE, Williams JV. 2010. Soluble recombinant human metapneumovirus G protein is immunogenic but not protective. Vaccine 28:4145-4152. http://dx.doi.org/10 .1016/j.vaccine.2010.04.007.
14. Biacchesi S, Skiadopoulos MH, Yang L, Lamirande EW, Tran KC, Murphy BR, Collins PL, Buchholz UJ. 2004. Recombinant human metapneumovirus lacking the small hydrophobic SH and/or attachment G glycoprotein: deletion of G yields a promising vaccine candidate. J. Virol. 78:12877-12887. http://dx.doi.org/10.1128/JVI.78.23.12877-12887.2004.
15. Thammawat S, Sadlon TA, Hallsworth PG, Gordon DL. 2008. Role of cellular glycosaminoglycans and charged regions of viral G protein in human metapneumovirus infection. J. Virol. 82:11767-11774. http://dx.doi .org/10.1128/JVI.01208-08.
16. Adamson P, Thammawat S, Muchondo G, Sadlon T, Gordon D. 2012. Diversity in glycosaminoglycan binding amongst hMPV G protein lineages. Viruses 4:3785-3803. http://dx.doi.org/10.3390/v4123785.
17. Bao X, Liu T, Shan Y, Li K, Garofalo RP, Casola A. 2008. Human metapneumovirus glycoproteinGinhibits innate immune responses. PLoS Pathog. 4:e1000077. http://dx.doi.org/10.1371/journal.ppat.1000077.
18. Kolli D, Bao X, Liu T, Hong C, Wang T, Garofalo RP, Casola A. 2011. Human metapneumovirus glycoprotein G inhibits TLR4-dependent signaling in monocyte-derived dendritic cells. J. Immunol. 187:47-54. http: //dx.doi.org/10.4049/jimmunol.1002589.
19. Velayutham TS, Kolli D, Ivanciuc T, Garofalo RP, Casola A. 2013. Critical role of TLR4 in human metapneumovirus mediated innate immune responses and disease pathogenesis. PLoS One 8:e78849. http://dx .doi.org/10.1371/journal.pone.0078849.
20. Preston FM, Straub CP, Ramirez R, Mahalingam S, Spann KM. 2012. siRNA against the G gene of human metapneumovirus. Virol. J. 9:105. http://dx.doi.org/10.1186/1743-422X-9-105.
21. van den Hoogen BG, van Boheemen S, de Rijck J, van Nieuwkoop S, Smith DJ, Laksono B, Gultyaev A, Osterhaus AD, Fouchier RA. 2014. Excessive production and extreme editing of human metapneumovirus defective interfering RNA is associated with type I interferon induction. J. Gen. Virol. 95:1625-1633. http://dx.doi.org/10.1099/vir.0.066100-0.
22. Le Nouen C, Hillyer P, Brock LG, Winter CC, Rabin RL, Collins PL, Buchholz UJ. 2014. Human metapneumovirus SH and G glycoproteins inhibit macropinocytosis-mediated entry into human dendritic cells and reduce CD4± T cell activation. J. Virol. 88:6453-6469. http://dx.doi.org /10.1128/JVI.03261-13.
23. Biacchesi S, Skiadopoulos MH, Boivin G, Hanson CT, Murphy BR, Collins PL, Buchholz UJ. 2003. Genetic diversity between human metapneumovirus subgroups. Virology 315:1-9. http://dx.doi.org/10.1016 /S0042-6822(03)00528-2.
24. Bastien N, Liu L, Ward D, Taylor T, Li Y. 2004. Genetic variability of the G glycoprotein gene of human metapneumovirus. J. Clin. Microbiol. 42: 3532-3537. http://dx.doi.org/10.1128/JCM.42.8.3532-3537.2004.
25. Ishiguro N, Ebihara T, Endo R, Ma X, Kikuta H, Ishiko H, Kobayashi K. 2004. High genetic diversity of the attachment (G) protein of human metapneumovirus. J. Clin. Microbiol. 42:3406-3414. http://dx.doi.org/10 .1128/JCM.42.8.3406-3414.2004.
26. van den Hoogen BG, Herfst S, Sprong L, Cane PA, Forleo-Neto E, de Swart RL, Osterhaus AD, Fouchier RA. 2004. Antigenic and genetic variability of human metapneumoviruses. Emerg. Infect. Dis. 10:658-666. http://dx.doi.org/10.3201/eid1004.030393.
27. Tripp RA, Jones LP, Haynes LM, Zheng H, Murphy PM, Anderson LJ. 2001. CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein. Nat. Immunol. 2:732-738. http://dx.doi.org/10.1038/90675.
28. Polack FP, Irusta PM, Hoffman SJ, Schiatti MP, Melendi GA, Delgado MF, Laham FR, Thumar B, Hendry RM, Melero JA, Karron RA, Collins PL, Kleeberger SR. 2005. The cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxin. Proc. Natl. Acad. Sci. U. S. A. 102:8996-9001. http://dx .doi.org/10.1073/pnas.0409478102.
29. Bukreyev A, Serra ME, Laham FR, Melendi GA, Kleeberger SR, Collins PL, Polack FP. 2006. The cysteine-rich region and secreted form of the attachment G glycoprotein of respiratory syncytial virus enhance the cytotoxic T-lymphocyte response despite lacking major histocompatibility complex class I-restricted epitopes. J. Virol. 80:5854-5861. http://dx.doi .org/10.1128/JVI.02671-05.
30. Aricescu AR, Lu W, Jones EY. 2006. A time-and cost-efficient system for high-level protein production in mammalian cells. Acta Crystallogr. D Biol. Crystallogr. 62:1243-1250. http://dx.doi.org/10.1107/S0907444906029799.
31. Wyatt PJ. 1998. Submicrometer particle sizing by multiangle light scattering following fractionation. J. Colloid Interface Sci. 197:9-20.
32. Verdugo P. 1991. Mucin exocytosis. Am. Rev. Respir. Dis. 144:S33-S37.
33. Receveur-Brechot V, Durand D. 2012. How random are intrinsically disordered proteins?Asmall angle scattering perspective. Curr. Prot. Pept. Sci. 13:55-75. http://dx.doi.org/10.2174/138920312799277901.
34. Bernado P, Mylonas E, Petoukhov MV, Blackledge M, Svergun DI. 2007. Structural characterization of flexible proteins using small-angle X-ray scattering. J. Am. Chem. Soc. 129:5656-5664. http://dx.doi.org/10 .1021/ja069124n.
35. Pelikan M, Hura GL, Hammel M. 2009. Structure and flexibility within proteins as identified through small angle X-ray scattering. Gen. Physiol. Biophys. 28:174-189. http://dx.doi.org/10.4149/gpb_2009_02_174.
36. Loo LH, Jumat MR, Fu Y, Ayi TC, Wong PS, Tee NW, Tan BH, Sugrue RJ. 2013. Evidence for the interaction of the human metapneumovirus G and F proteins during virus-like particle formation. Virol. J. 10:294. http: //dx.doi.org/10.1186/1743-422X-10-294.
37. Low KW, Tan T, Ng K, Tan BH, Sugrue RJ. 2008. The RSV F and G glycoproteins interact to form a complex on the surface of infected cells. Biochem. Biophys. Res. Commun. 366:308-313. http://dx.doi.org/10 .1016/j.bbrc.2007.11.042.
38. McLellan JS, Chen M, Leung S, Graepel KW, Du X, Yang Y, Zhou T, Baxa U, Yasuda E, Beaumont T, Kumar A, Modjarrad K, Zheng Z, Zhao M, Xia N, Kwong PD, Graham BS. 2013. Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody. Science 340:1113-1117. http://dx.doi.org/10.1126/science.1234914.
39. Swanson KA, Settembre EC, Shaw CA, Dey AK, Rappuoli R, Mandl CW, Dormitzer PR, Carfi A. 2011. Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers. Proc. Natl. Acad. Sci. U. S. A. 108:9619-9624. http://dx.doi.org/10.1073/pnas.1106536108.
40. Swanson K, Wen X, Leser GP, Paterson RG, Lamb RA, Jardetzky TS. 2010. Structure of the Newcastle disease virus F protein in the post-fusion conformation. Virology 402:372-379. http://dx.doi.org/10.1016/j.virol .2010.03.050.
41. Yin HS, Wen X, Paterson RG, Lamb RA, Jardetzky TS. 2006. Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation. Nature 439:38-44. http://dx.doi.org/10.1038/nature04322.
42. Wen X, Krause JC, Leser GP, Cox RG, Lamb RA, Williams JV, Crowe JE, Jr., Jardetzky TS. 2012. Structure of the human metapneumovirus fusion protein with neutralizing antibody identifies a pneumovirus antigenic site. Nat. Struct. Mol. Biol. 19:461-463. http://dx.doi.org/10.1038 /nsmb.2250.
43. Escribano-Romero E, Rawling J, Garcia-Barreno B, Melero JA. 2004. The soluble form of human respiratory syncytial virus attachment protein differs from the membrane-bound form in its oligomeric state but is still capable of binding to cell surface proteoglycans. J. Virol. 78:3524-3532. http://dx.doi.org/10.1128/JVI.78.7.3524-3532.2004.
44. Rallabhandi P, Phillips RL, Boukhvalova MS, Pletneva LM, Shirey KA, Gioannini TL, Weiss JP, Chow JC, Hawkins LD, Vogel SN, Blanco JC. 2012. Respiratory syncytial virus fusion protein-induced Toll-like receptor 4 (TLR4) signaling is inhibited by the TLR4 antagonists Rhodobacter sphaeroides lipopolysaccharide and eritoran (E5564) and requires direct interaction with MD-2. mBio 3(4):e00218-12. http://dx.doi.org/10.1128 /mBio.00218-12.
45. Shoemaker BA, Portman JJ, Wolynes PG. 2000. Speeding molecular recognition by using the folding funnel: the fly-casting mechanism. Proc. Natl. Acad. Sci. U. S. A. 97:8868-8873. http://dx.doi.org/10.1073/pnas .160259697.
46. Huang Y, Liu Z. 2009. Kinetic advantage of intrinsically disordered proteins in coupled folding-binding process: a critical assessment of the "flycasting" mechanism. J. Mol. Biol. 393:1143-1159. http://dx.doi.org/10 .1016/j.jmb.2009.09.010.
47. Leventis R, Silvius JR. 2010. Quantitative experimental assessment of macromolecular crowding effects at membrane surfaces. Biophys. J. 99: 2125-2133. http://dx.doi.org/10.1016/j.bpj.2010.07.047.
48. Mok H, Tollefson SJ, Podsiad AB, Shepherd BE, Polosukhin VV, Johnston RE, Williams JV, Crowe JE, Jr. 2008. An alphavirus repliconbased human metapneumovirus vaccine is immunogenic and protective in mice and cotton rats. J. Virol. 82:11410-11418. http://dx.doi.org/10 .1128/JVI.01688-08.
49. Bennett RS, LaRue R, Shaw D, Yu Q, Nagaraja KV, Halvorson DA, Njenga MK. 2005. A wild goose metapneumovirus containing a large attachment glycoprotein is avirulent but immunoprotective in domestic turkeys. J. Virol. 79:14834-14842. http://dx.doi.org/10.1128/JVI.79.23 .14834-14842.2005.
50. Yu Q, Estevez C, Song M, Kapczynski D, Zsak L. 2009. Generation and biological assessment of recombinant avian metapneumovirus subgroup C (aMPV-C) viruses containing different length of the G gene. Virus Res. 147:182-188. http://dx.doi.org/10.1016/j.virusres.2009.10.021.
51. Cha RM, Yu Q, Zsak L. 2013. The pathogenicity of avian metapneumo-virus subtype C wild bird isolates in domestic turkeys. Virol. J. 10:38. http: //dx.doi.org/10.1186/1743-422X-10-38.
52. Jardetzky TS, Lamb RA. 2014. Activation of paramyxovirus membrane fusion and virus entry. Curr. Opin. Virol. 5:24-33. http://dx.doi.org/10 .1016/j.coviro.2014.01.005.
53. Plattet P, Plemper RK. 2013. Envelope protein dynamics in paramyxovirus entry. mBio 4(4):e00413-13. http://dx.doi.org/10.1128 /mBio.00413-13.
54. Francica JR, Varela-Rohena A, Medvec A, Plesa G, Riley JL, Bates P. 2010. Steric shielding of surface epitopes and impaired immune recognition induced by the Ebola virus glycoprotein. PLoS Pathog. 6:e1001098. http://dx.doi.org/10.1371/journal.ppat.1001098.
55. Reynard O, Borowiak M, Volchkova VA, Delpeut S, Mateo M, Volchkov VE. 2009. Ebolavirus glycoprotein GP masks both its own epitopes and the presence of cellular surface proteins. J. Virol. 83:9596-9601. http: //dx.doi.org/10.1128/JVI.00784-09.
56. Blondot ML, Dubosclard V, Fix J, Lassoued S, Aumont-Nicaise M, Bontems F, Eleouet JF, Sizun C. 2012. Structure and functional analysis of the RNA-and viral phosphoprotein-binding domain of respiratory syncytial virus M2-1 protein. PLoS Pathog. 8:e1002734. http://dx.doi.org /10.1371/journal.ppat.1002734.
57. Leyrat C, Renner M, Harlos K, Huiskonen JT, Grimes JM. 2014. Structure and self-assembly of the calcium binding matrix protein of human metapneumovirus. Structure 22:136-148. http://dx.doi.org/10.1016 /j.str.2013.10.013.
58. Leyrat C, Renner M, Harlos K, Huiskonen JT, Grimes JM. 2014. Drastic changes in conformational dynamics of the antiterminator M2-1 regulate transcription efficiency in Pneumovirinae. eLife:e02674. http://dx.doi.org /10.7554/eLife.02674.
59. Gerard FC, Ribeiro Ede A, Jr., Leyrat C, Ivanov I, Blondel D, Longhi S, Ruigrok RW, Jamin M. 2009. Modular organization of rabies virus phosphoprotein. J. Mol. Biol. 388:978-996. http://dx.doi.org/10.1016/j.jmb .2009.03.061.
60. Pei J, Grishin NV. 2001. AL2CO: calculation of positional conservation in a protein sequence alignment. Bioinformatics 17:700-712. http://dx.doi .org/10.1093/bioinformatics/17.8.700.
61. Hamby SE, Hirst JD. 2008. Prediction of glycosylation sites using random forests. BMC Bioinformatics 9:500. http://dx.doi.org/10.1186/1471-2105 -9-500.
62. Svergun D. 1992. Determination of the regularization parameter in indirect-transform methods using perceptual criteria. J. Appl. Cryst. 25:495-
63. Tosatto SC. 2005. The victor/FRST function for model quality estimation. J. Comput. Biol. 12:1316-1327. http://dx.doi.org/10.1089/cmb.2005.12 .1316.